HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusion.

Abstract
Glial cell line-derived trophic factor (GDNF) is a peptide with pleiotropic survival and growth-promoting effects on neurons. We found that intraspinal injection of a non-replicating herpes simplex virus-based vector coding for GDNF 2 h after blunt trauma to the thoraco-lumbar spinal cord produced sustained improvement in motor behavioral outcomes up to 5 weeks following injury. The improvement in behavior correlated with an increase in synaptophysin and glutamic acid decarboxylase (GAD) in the spinal cord at the level of injury. Addition of recombinant GDNF protein to primary spinal cord neurons in-vitro resulted in enhanced neurite growth and a marked increase in protein levels of GAD65 and GAD67, synapsin I and synaptophysin. GDNF-mediated increases in GAD and the synaptic markers were blocked by the MEK inhibitor UO126, but not by the phosphoinositide 3-kinase inhibitor LY294002. These results suggest that GDNF, acting through the MEK-ERK pathway enhances axonal sprouting, synaptic connectivity, and GABAergic neurotransmission in the spinal cord, that result in improved behavioral outcomes after spinal cord contusion injury.
AuthorsAngela Koelsch, Yongjia Feng, David J Fink, Marina Mata
JournalJournal of neurochemistry (J Neurochem) Vol. 113 Issue 1 Pg. 143-52 (Apr 2010) ISSN: 1471-4159 [Electronic] England
PMID20132484 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Glial Cell Line-Derived Neurotrophic Factor
  • Microtubule-Associated Proteins
  • Mtap2 protein, rat
  • Neurofilament Proteins
  • Green Fluorescent Proteins
  • gamma-Aminobutyric Acid
  • Glutamate Decarboxylase
  • glutamate decarboxylase 1
  • glutamate decarboxylase 2
Topics
  • Analysis of Variance
  • Animals
  • Cells, Cultured
  • Disease Models, Animal
  • Embryo, Mammalian
  • Female
  • Genetic Therapy (methods)
  • Glial Cell Line-Derived Neurotrophic Factor (genetics, metabolism, pharmacology)
  • Glutamate Decarboxylase (metabolism)
  • Green Fluorescent Proteins (genetics)
  • Humans
  • Microtubule-Associated Proteins (metabolism)
  • Motor Activity (drug effects, genetics)
  • Neurofilament Proteins (metabolism)
  • Neurons (drug effects, metabolism)
  • Psychomotor Performance (drug effects, physiology)
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function (genetics, physiology)
  • Spinal Cord (cytology)
  • Spinal Cord Injuries (genetics, pathology, physiopathology, therapy)
  • Synaptic Transmission (drug effects, genetics)
  • gamma-Aminobutyric Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD